CARISTO DIAGNOSTICS LIMITED

No Analysis Available

Get instant AI-powered insights about this company's financial health, risks, and trends.

Order Analysis - £10
Legal registered address
New Barclay House 234 Botley Road Oxford United Kingdom OX2 0HP Copied!
Company received £139,086 of state aid to support it through COVID-19 more details

Latest financial results as of 2 August 2025
Cash in bank
£2.22m
Current assets
£3.50m
Current creditors
£927.52k
Shareholders funds
£10.30m
View full financial accounts

Company number
11429590 Copied!
Company status
Active
Company type
Private Limited Company
Accounts category
Small
Incorporated on
22 June 2018
Accounts

Latest annual accounts were to 31 December 2023

Next annual accounts are due by 30 September 2025

Company financial year end is on 31 December 2025

Confirmation statement

Latest confirmation statement statement dated 21 June 2025

Next statement due by 5 July 2026

View original and historic source data
Nature of business (SIC)

86220 - Specialists medical practice activities

Previous company names

NameDate previous name changed
CARISTO TECHNOLOGIES LIMITED9 July 2018

Latest company documents
DateDescription
09/06/259 June 2025 NewNotification of Oxford Science Enterprises Holdings Limited as a person with significant control on 2025-03-31

View Document

09/06/259 June 2025 NewCessation of Oxford Science Enterprises Plc as a person with significant control on 2025-03-31

View Document

09/05/259 May 2025 Termination of appointment of Oran Efruz Muduroglu as a director on 2025-04-01

View Document

11/04/2511 April 2025 Termination of appointment of Ian Downing as a director on 2025-04-02

View Document

11/04/2511 April 2025 Appointment of Mr Timothy Shan Rea as a director on 2025-04-02

View Document

View all company documents

More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company